2026 Artemetrx State of Specialty Spend and Trend Report
PSG announces the results of the industry’s go-to report on specialty drug spend and trend. With specialty drug costs remaining a top concern…
Read Post
Insights
Categories
Topics
Categories
Topics
GLP-1 Resource Hub
Resources to Support Payers’ GLP-1 Strategies GLP-1s are a class of medications that can help manage type 2 diabetes and obesity. In recent years,…
Read Post
GLP-1 Trends Infographic
Learn more about trends in GLP-1 perceptions and coverage strategies Obesity is one of the largest public health concerns in the United States, and…
Read Post
Pharmaceutical Strategies Group Releases Artemetrx State of Specialty Spend and Trend Report
DALLAS, TX – June 11, 2024 – Pharmaceutical Strategies Group (“PSG”), an EPIC company, releases its proprietary Artemetrx® State of Specialty…
Read Post
2024 PBM Customer Satisfaction Report Webinar
PSG announces the results of the industry’s go-to report on pharmacy benefit manager (PBM) customer satisfaction. Join industry experts Michael Lonergan and Morgan…
Read Post
2024 State of Specialty Spend and Trend Report
With specialty drug spend on the rise and a robust pipeline of specialty drugs, specialty drug management remains a top concern for payers. The…
Read Post
New FTC Report Critiques PBMs: What Does This Mean For Payers?
Payers must carve A path forward As A Result Of The Recent FTC Report On July 9, 2024, the Federal Trade Commission (FTC) released…
Read Post
Pharmaceutical Strategies Group Announces the Expansion of its Government Pharmacy Program Services
New team members and services will strengthen PSG’s expertise and capabilities to support clients with Government Programs DALLAS – July 10, 2024 – Pharmaceutical…
Read Post
Medication Shortages Impact Patients and Payers
Plan sponsors must address the impact of medication shortages as they plan for the future. In September 2023, I published a…
Read Post
The Medicare Prescription Payment Plan: Considerations For Upcoming M3P Compliance
M3P deadlines are approaching fast, but plans can prepare for M3P compliance in several ways. As part of the Inflation Reduction Act (IRA), Congress…
Read Post
Obesity GLP-1 Coverage and Weight Management Vendor Considerations
2024 Trends in Drug Benefit Design Report Issue Brief Obesity is one of the largest public health concerns in the United States, as it…
Read Post
The Rise of Integrated Discount Card Programs
Discount card programs require thoughtfulness when implemented within a pharmacy benefit Drug discount cards have been around for several years, but their recent usage…
Read Post